Loading
Latest filing published 12 Mar 2026 for 비보존 제약, €29k. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
이두현 (board member) discloses dealings in 비보존 제약 to DART (FSS). Over a trading history stretching from 19 February 2021 to 5 March 2026, the count stands at 28 filings.
No open-market sale appears; the market trades are 5 purchases worth €29k. The totals exclude 4 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2026, the count stands at 2 purchases and no sales.
On 1 out of 4 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The newest entry dates from 12 March 2026: an open-market purchase of €29k, in 비보존 제약. The median gap between a trade and its publication by DART (FSS) is 7 days. That lag is the time during which only the insider knows about the trade. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 28 declarations